Key result
In non-obese, non-diabetic individuals, increasing body mass index was associated with impaired protective functions of HDL, including reduced cholesterol efflux capacity, and a concomitant increase in atherosclerotic burden.
Why the study?
Obesity-related decline in HDL functions contributes to atherogenesis, but whether other protective actions are affected with weight gain before the obesity range remained unclear.
Does increased BMI alter HDL protective functions and increase atherosclerotic burden in asymptomatic individuals?
Cross-Sectional (n=899)
Yes
Does increased BMI alter HDL protective functions and increase atherosclerotic burden in asymptomatic individuals?
Effect estimate: β=-0.18 (95% CI -0.138 to -0.011)
p-value: p=0.02
Even in non-obese, non-diabetic individuals, increasing BMI is associated with impaired HDL protective functions and an increased atherosclerotic burden as measured by cIMT.
Higher BMI may impair HDL function and raise cIMT even in non-obese non-diabetics; hypothesis-generating and should not change practice.
Objective Obesity-related decline in high-density lipoprotein (HDL) functions such as cholesterol efflux capacity (CEC) has supported the notion that this lipoprotein dysfunction may contribute for atherogenesis among obese patients. Besides, potentially other HDL protective actions may be affected with weight gain and these changes may occur even before the obesity range. Methods Lipid profile, body mass index (BMI), biochemical measurements, and carotid intima-media thickness (cIMT) were obtained in this cross-sectional study with 899 asymptomatic individuals. HDL functions were measured in a subgroup (n=101). Results Individuals with increased HDL-C had an attenuated increase in cIMT with elevation of BMI. CEC, HDL-C, HDL size and HDL-antioxidant activity were negatively associated with cIMT. BMI was inversely associated with HDL-mediated inhibition of platelet aggregation and CEC, but surprisingly it was directly associated with the antioxidant activity. Thus, even in non-obese, non-diabetic individuals, increased BMI is associated with a wide change in protective functions of HDL, reducing CEC and increasing antioxidant activity. In these subjects, decreased HDL concentration, size or function are related to increased atherosclerotic burden. Conclusion Our findings demonstrate that in non-obese, non-diabetic individuals, the increasing values of BMI are associated with impaired protective functions of HDL and concomitant increase in atherosclerotic burden.
No takes yet. Share an insight, caveat, or question.
Júnior et al. (2019) conducted a cross-sectional in Asymptomatic individuals without manifested atherosclerotic cardiovascular disease or type 2 diabetes (n=899). Body mass index vs. Lower body mass index was evaluated on Association between cholesterol efflux capacity (CEC) and carotid intima-media thickness (cIMT) adjusted for HDL size (β=-0.18, 95% CI -0.138 to -0.011, p=0.02). In non-obese, non-diabetic individuals, increasing body mass index was associated with impaired protective functions of HDL, including reduced cholesterol efflux capacity, and a concomitant increase in atherosclerotic burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: